The phCMV Fusion Stable Reporter (FSR) Vectors are designed for high-level expression of GFP or Luciferase fusion proteins and for creating GFP or Luciferase stable cell lines. These innovative vectors contain optimized CMV promoter-intron sequences for significantly higher constitutive expression levels than other mammalian expression vectors. Each phCMV-FSR Vector contains a multiple cloning site on either side of the reporter gene for creating N- or C-terminal fusion proteins. Also, each vector contains a combination Kanamycin/Neomycin antibiotic selection gene, which allows for selection in both E. coli and mammalian cells, while minimizing vector size so that transfection efficiency is maximally enhanced. The vectors can be used for either transient transfection or for generating stable cells lines expressing the reporter gene only or your fusion-reporter gene construct.
The phCMV-FSR Vectors provide the following features and benefits:| Feature |
Benefit |
Modified hCMV immediate-early promoter |
High level constitutive expression pomoter in a wide variety of cells and cell types. |
| Reporter genes |
Convenient choice of GFP or Luciferase reporter genes for control expression experiments. |
| SV40 polyadenylation signal |
Stable mRNA by providing efficient transcription termination and polyadenylation. |
| Kanamycin/Neomycin resistance gene |
Efficient vector selection in E. coli (with Kanamycin sulfate) or mammalian cells (with Neomycin Sulfate) |
| PUC Origin of replication |
High copy number replication of vector in E. coli. |
| Two multiple cloning sites (MCS) |
For cloning gene of choice upstream or downstream of reporter gene (in fusion). |
Shipping/Storage:
Store at -20ºC
Stable for 1 year
phCMV N-Luciferase Vector, 20 µg - P013500 $435
phCMV C-GFP FSR Vector, 20 µg - P003400 $435
phCMV C-Luciferase FSR Vector, 20 µg - P003500 $435
phCMV N-GFP FSR Vector, 20 µg - P013400 $435
The phCMV Fusion Stable Reporter (FSR) Vectors are designed for high-level expression of GFP or Luciferase fusion proteins and for creating GFP or Luciferase stable cell lines. These innovative vectors contain optimized CMV promoter-intron sequences for significantly higher constitutive expression levels than other mammalian expression vectors. Each phCMV-FSR Vector contains a multiple cloning site on either side of the reporter gene for creating N- or C-terminal fusion proteins. Also, each vector contains a combination Kanamycin/Neomycin antibiotic selection gene, which allows for selection in both E. coli and mammalian cells, while minimizing vector size so that transfection efficiency is maximally enhanced. The vectors can be used for either transient transfection or for generating stable cells lines expressing the reporter gene only or your fusion-reporter gene construct.
The phCMV-FSR Vectors provide the following features and benefits:| Feature |
Benefit |
Modified hCMV immediate-early promoter |
High level constitutive expression pomoter in a wide variety of cells and cell types. |
| Reporter genes |
Convenient choice of GFP or Luciferase reporter genes for control expression experiments. |
| SV40 polyadenylation signal |
Stable mRNA by providing efficient transcription termination and polyadenylation. |
| Kanamycin/Neomycin resistance gene |
Efficient vector selection in E. coli (with Kanamycin sulfate) or mammalian cells (with Neomycin Sulfate) |
| PUC Origin of replication |
High copy number replication of vector in E. coli. |
| Two multiple cloning sites (MCS) |
For cloning gene of choice upstream or downstream of reporter gene (in fusion). |
Shipping/Storage:
Store at -20ºC
Stable for 1 year
phCMV N-Luciferase Vector, 20 µg - P013500 $435
phCMV C-GFP FSR Vector, 20 µg - P003400 $435
phCMV C-Luciferase FSR Vector, 20 µg - P003500 $435
phCMV N-GFP FSR Vector, 20 µg - P013400 $435



